Profilo
Phillip Zamore is the founder of Alnylam Pharmaceuticals, Inc., founded in 2002.
Dr. Zamore is the founder of Voyager Therapeutics, Inc., founded in 2013.
Dr. Zamore currently holds the position of Chairman at RNA Therapeutics Institute.
Dr. Zamore currently holds the position of Professor at UMass Chan Medical School.
Dr. Zamore completed undergraduate and doctorate degrees at Harvard University.
Posizioni attive di Phillip Zamore
| Società | Posizione | Inizio |
|---|---|---|
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
RNA Therapeutics Institute | Presidente | - |
Precedenti posizioni note di Phillip Zamore
| Società | Posizione | Fine |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Fondatore | - |
| VOYAGER THERAPEUTICS, INC. | Fondatore | - |
Formazione di Phillip Zamore
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
RNA Therapeutics Institute |
















